Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 01, 2007 (Vol. 27, No. 19)

Combinatorial Chemistry Review

URL:www.combichemistry.com
  • Broad coverage of topic
  • A bit too techie for general interest
When it comes to drug design, the technique of combinatorial chemistry is rapidly taking over the subject. Covering this important area is Combinatorial Chemistry Review, a site providing an overview of combinatorial synthesis with aims of providing insights to the field by describing major techniques and applications of them. Highlights of Combinatorial Chemistry Review (CCR) include a short description of the strategy of the technique, another description of resins used for solid-state synthesis, theoretical considerations for synthesis, an informative glossary, news/events, and a wide collection of useful links. The site could use a bit more of an educational focus for nontechies, but that is a relatively minor concern. CCR is an important site for anyone interested in the subject of combinatorial chemistry.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »